Serious adverse events included neutropenia (n = 9), elevation in hepatic enzymes (alanine aminotransferase, gamma-glutamyl transferase, serum glutamic oxaloacetic transaminase; n = 6), hematologic abnormalities (n = 5), and depression (n = 2). The gene discussed is GPT; the disease is depressive disorder.